Article
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
2023-10-23
Abstract excerpt
Cysteine-focused chemical proteomic platforms have accelerated the clinical development of covalent inhibitors of a wide-range of targets in cancer. However, how different oncogenic contexts influence cysteine targeting remains unknown. To address this question, we have developed DrugMap , an atlas of cysteine ligandability compiled across 416 cancer cell lines. We unexpectedly find that cysteine ligandability va...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ad44742d-62a7-584f-bd6e-6f4fecbd2def
- DOI
- 10.1101/2023.10.20.563287
